The US Centers for Disease Control and Prevention worked with the Food and Drug Administration to fix faulty COVID-19 assays it previously sent to all 50 state laboratories, with the result that new, improved test reagents will be sent back next week to states that need it, CDC director Redfield told Congress on 26 February.
The CDC first reported glitches in some of the tests that were sent out two weeks ago, leaving only 12 laboratories in the US with adequate diagnostics to detect freshly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?